id,agency_id,docket_id,title,document_type,subtype,posted_date,posted_year,posted_month,comment_start_date,comment_end_date,last_modified,fr_doc_num,open_for_comment,withdrawn,object_id
FDA-2003-E-0329-0006,FDA,FDA-2003-E-0329,Letter from FDA CDER to U.S. Patent and Trademark Office,Other,Letter(s),2004-06-28T04:00:00Z,2004,6,,,2025-10-28T17:55:06Z,,0,0,0900006480495956
FDA-2003-E-0329-0005,FDA,FDA-2003-E-0329,Determination of Regulatory Review Period for Purposes of Patent Extension; STRATTERA,Notice,General Notice,2003-12-05T05:00:00Z,2003,12,2003-12-03T05:00:00Z,,2025-10-28T17:50:57Z,03-30028,0,0,0900006480495953
FDA-2003-E-0329-0004,FDA,FDA-2003-E-0329,Letter from FDA CDER to U.S. Patent and Trademark Office,Other,Letter(s),2003-11-12T05:00:00Z,2003,11,,,2025-10-28T17:45:49Z,,0,0,0900006480495951
FDA-2003-E-0329-0003,FDA,FDA-2003-E-0329,Letter from U.S. Patent and Trademark Office to FDA CDER,Other,Letter(s),2003-10-06T04:00:00Z,2003,10,,,2025-10-28T17:43:24Z,,0,0,090000648049594f
FDA-2003-E-0329-0002,FDA,FDA-2003-E-0329,Letter from FDA CDER to U.S. Patent and Trademark Office,Other,Letter(s),2003-07-29T04:00:00Z,2003,7,,,2025-10-28T17:39:35Z,,0,0,090000648049594d
FDA-2003-E-0329-0001,FDA,FDA-2003-E-0329,Letter from U.S. Patent and Trademark Office to FDA CDER,Other,Letter(s),2003-06-09T04:00:00Z,2003,6,,,2025-10-28T17:37:02Z,,0,0,09000064804958fb